Temporal trends of the in vitro activity of tigecycline and comparator antibiotics against clinical aerobic bacterial isolates collected in Germany, 2006–2014: results of the Tigecycline Evaluation and Surveillance Trial (TEST)

2016/10/04 by Michael Kresken, Barbara Körber-Irrgang, Kresken, Michael +9
Biochemistry, Genetics and Molecular Biology · Medicine · #610 Medical sciences #Antibiotic Resistance in Bacteria #Antibiotics Pharmacokinetics and Efficacy #Bacterial Identification and Susceptibility Testing #Germany #Medicine #Tigecycline Evaluation and Surveillance Trial (TEST) #antimicrobial susceptibility #extended-spectrum beta-lactamase #methicillin-resistant Staphylococcus aureus #multidrug resistance #tigecycline #vancomycin-resistant enterococci

paper · doi:10.3205/id000025

openalex publication_date 2016/10/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/28

Abstract

and vancomycin-resistant enterococci. Across the reporting period, the tigecycline minimum inhibitory concentrations (MICs) at which 50% and 90% of isolates were inhibited remained stable and susceptibility rates were consistently high (93-100%) for all bacterial species.

Citations

• Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen

Related

• Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study
• Residence in Skilled Nursing Facilities Is Associated with Tigecycline Nonsusceptibility in Carbapenem-Resistant Klebsiella pneumoniae
• Antimicrobial susceptibility patterns of Escherichia coli from various clinical sources
• Results on the mandatory notification of carbapenem-resistant Gram-negative bacteria, Hesse, Germany, January 2012 – April 2013
• Carbapenem Resistant Gram-Negative Organisms: Therapeutic Options In A Resource Limited Setting